Glucans as New Anticancer Agents
Jazyk angličtina Země Řecko Médium print
Typ dokumentu časopisecké články, přehledy
PubMed
31262858
DOI
10.21873/anticanres.13480
PII: 39/7/3373
Knihovny.cz E-zdroje
- Klíčová slova
- Glucan, cancer, fiber, immunity, nutrition, review,
- MeSH
- glukany farmakologie terapeutické užití MeSH
- lidé MeSH
- nádory farmakoterapie MeSH
- protinádorové látky farmakologie terapeutické užití MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
- Názvy látek
- glukany MeSH
- protinádorové látky MeSH
For decades, glucans have been studied for their biological and immunological activities. The scientific community has mainly focused on immune reactions, but other areas, such as cholesterol levels and diabetic retinopathy, have shown the positive effects of glucan supplementation. However, the majority of studies focused on possible cancer suppression, where glucans showed clear and significant effects on numerous types of cancers, leading not only to clinical trials, but to approval as an official drug. The aim of this review is to describe the current knowledge of this field.
Department of Immunology Institute of Microbiology Prague Czech Republic
Department of Pathology and Laboratory Medicine University of Louisville Louisville KY U S A
Institute of Public Health in Usti nad Labem Ústí nad Labem Czech Republic
Citace poskytuje Crossref.org
Trained Immunity as an Adaptive Branch of Innate Immunity